INVESTMENTS AND FAIR VALUE MEASUREMENTS (Tables)
|
3 Months Ended |
Jul. 31, 2026 |
| INVESTMENTS AND FAIR VALUE MEASUREMENTS |
|
| Schedule of current investments |
|
|
|
|
|
|
|
|
|
Investments - current |
|
July 31, 2026 |
|
|
April 30, 2026 |
|
Marketable equity securities |
|
$ |
34,698 |
|
|
$ |
42,168 |
|
Total Investments – current |
|
$ |
34,698 |
|
|
$ |
42,168 |
|
|
| Schedule of short-term investments |
Marketable securities as of July 31, 2026 and April 30, 2026 consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 31, 2026 |
|
|
|
Cost or Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Marketable equity securities |
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities |
|
$ |
36,121 |
|
|
$ |
6,838 |
|
|
$ |
(8,261 |
) |
|
$ |
34,698 |
|
Total marketable securities |
|
$ |
36,121 |
|
|
$ |
6,838 |
|
|
$ |
(8,261 |
) |
|
$ |
34,698 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30, 2026 |
|
|
|
Cost or Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Marketable equity securities |
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities |
|
$ |
47,087 |
|
|
$ |
5,365 |
|
|
$ |
(10,284 |
) |
|
$ |
42,168 |
|
Total marketable securities |
|
$ |
47,087 |
|
|
$ |
5,365 |
|
|
$ |
(10,284 |
) |
|
$ |
42,168 |
|
|
| Derivatives Not Designated as Hedging Instruments |
Immersion’s derivative instruments consisted of call and put options sold at their fair value as of the balance sheet date. These derivative instruments are reported as Other current liabilities on the Company’s Condensed Consolidated Balance Sheets as of July 31, 2026 and April 30, 2026 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 31, 2026 |
|
|
|
Cost |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Derivative instruments |
|
$ |
21,365 |
|
|
$ |
1,309 |
|
|
$ |
22,674 |
|
|
|
$ |
21,365 |
|
|
$ |
1,309 |
|
|
$ |
22,674 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30, 2026 |
|
|
|
Cost |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Derivative instruments |
|
$ |
10,690 |
|
|
$ |
1,185 |
|
|
$ |
11,875 |
|
|
|
$ |
10,690 |
|
|
$ |
1,185 |
|
|
$ |
11,875 |
|
|
| Schedule of realized and unrealized gains and losses from equity securities and derivative instruments and realized gains and losses from marketable debt securities |
The following summarizes the realized and unrealized gains and losses from Immersion’s equity securities and derivative instruments and realized gains and losses from our marketable-debt securities for the following periods (in thousands):
|
|
|
|
|
|
|
|
|
Three Months Ended July 31, |
|
|
2026 |
|
|
2025 |
|
Net unrealized gains recognized on marketable equity securities |
$ |
3,496 |
|
|
$ |
1,243 |
|
Net realized gains recognized on marketable equity securities |
|
3,623 |
|
|
|
960 |
|
Net unrealized gains (losses) recognized on derivative instruments |
|
(124 |
) |
|
|
2,577 |
|
Net realized gains recognized on derivative instruments |
|
6,768 |
|
|
|
1,205 |
|
Total net gains recognized in interest income and other income (expense), net |
$ |
13,763 |
|
|
$ |
5,985 |
|
|
| Schedule of financial instruments measured at fair value on recurring basis |
Financial instruments measured at fair value on a recurring basis as of July 31, 2026 and April 30, 2026 are classified based on the valuation technique in the table below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 31, 2026 |
|
|
|
|
|
|
Fair Value Measurements Using |
|
|
|
|
|
|
Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
|
Significant Other Observable Inputs (Level 2) |
|
|
Significant Unobservable Inputs (Level 3) |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Money Market funds (within cash and cash equivalents) |
|
$ |
141,249 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
141,249 |
|
Equity securities |
|
|
34,698 |
|
|
|
— |
|
|
|
— |
|
|
|
34,698 |
|
Total assets at fair value |
|
$ |
175,947 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
175,947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments |
|
$ |
9,076 |
|
|
$ |
13,598 |
|
|
$ |
— |
|
|
|
22,674 |
|
Total liabilities at fair value |
|
$ |
9,076 |
|
|
$ |
13,598 |
|
|
$ |
— |
|
|
$ |
22,674 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 30, 2026 |
|
|
|
|
|
|
Fair Value Measurements Using |
|
|
|
|
|
|
Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
|
Significant Other Observable Inputs (Level 2) |
|
|
Significant Unobservable Inputs (Level 3) |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Money Market funds (within cash and cash equivalents) |
|
$ |
109,631 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
109,631 |
|
Equity securities |
|
|
42,168 |
|
|
|
— |
|
|
|
— |
|
|
|
42,168 |
|
Total assets at fair value |
|
$ |
151,799 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
151,799 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments |
|
$ |
2,166 |
|
|
$ |
9,709 |
|
|
$ |
— |
|
|
$ |
11,875 |
|
Total liabilities at fair value |
|
$ |
2,166 |
|
|
$ |
9,709 |
|
|
$ |
— |
|
|
$ |
11,875 |
|
|